Related Experiment Video
Updated: Feb 16, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
[Malign pleural mesothelioma - so far an undefeated tumor]
Abstract:
Malign pleural mesothelioma is the most frequent primary tumor of the pleura of high aggressiveness. Its most frequent cause is contact with asbestos and, although working with asbestos is already prohibited in developed countries, its incidence is on the increase so far. Diagnostics primarily considers anamnesis, clinical symptoms and immunohistochemical examination of a tumor sample. The basic therapy used over the past 10 years is chemotherapy with cisplatin - pemetrexed combinations. Numerous studies are going on with a different biologically targeted therapy, immunotherapy and other drugs which may improve patients prognosis. The surgical approach is limited by a suitable choice of patients and sufficient experience of the medical center. Extrapleural pneumonectomy or extended pleurectomy are performed. However even the combined therapy with adjuvant or neoadjuvant chemotherapy or radiotherapy has not considerably extended survival.Key words: diagnostics - epidemiology - malign pleural mesothelioma - therapy.
Insights
Malignant pleural mesothelioma, a highly aggressive cancer often caused by asbestos exposure, is increasing despite bans. Current treatments like chemotherapy offer limited survival benefits, prompting research into new therapies.
Area of Science:
- Oncology
- Epidemiology
- Thoracic Surgery
Background:
- Malignant pleural mesothelioma is the most common primary pleural tumor, characterized by high aggressiveness.
- Asbestos exposure is the primary cause, and incidence is rising despite occupational bans.
- Diagnosis relies on patient history, symptoms, and tumor biopsy with immunohistochemistry.
Purpose of the Study:
- To review the current diagnostic and therapeutic strategies for malignant pleural mesothelioma.
- To highlight the challenges and ongoing research in improving patient prognosis.
Main Methods:
- Review of current diagnostic approaches including anamnesis, clinical presentation, and immunohistochemistry.
- Analysis of standard chemotherapy regimens (cisplatin-pemetrexed).
- Overview of emerging therapies such as targeted therapy and immunotherapy, and surgical interventions (extrapleural pneumonectomy, extended pleurectomy).
Main Results:
- Standard chemotherapy with cisplatin-pemetrexed remains the primary treatment.
- Surgical options are limited to carefully selected patients and experienced centers.
- Combined therapies, including neoadjuvant/adjuvant chemotherapy or radiotherapy, have not significantly improved survival rates.
Conclusions:
- Malignant pleural mesothelioma presents diagnostic and therapeutic challenges due to its aggressiveness and increasing incidence.
- While current treatments offer limited survival gains, ongoing research into novel therapies holds promise.
- Multidisciplinary approaches and further research are crucial for improving outcomes for patients with this disease.
Related Concept Videos
01:25Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
01:30Pleural Disorders: Types and Brief Description
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:27Tumor Immunotherapy
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment